Literature DB >> 1741621

Ivermectin as an antiparasitic agent for use in humans.

W C Campbell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1741621     DOI： 10.1146/annurev.mi.45.100191.002305

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN： 0066-4227            Impact factor:   15.500


× No keyword cloud information.
  22 in total

1.  The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A.

Authors:  Jonathan G Bilmen; Laura L Wootton; Francesco Michelangeli
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

Review 2.  Diethylcarbamazine in the treatment of patients with onchocerciasis.

Authors:  K Awadzi; H M Gilles
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

3.  Ivermectin activates GIRK channels in a PIP2 -dependent, Gβγ -independent manner and an amino acid residue at the slide helix governs the activation.

Authors:  I-Shan Chen; Michihiro Tateyama; Yuko Fukata; Motonari Uesugi; Yoshihiro Kubo
Journal:  J Physiol       Date:  2017-07-30       Impact factor: 5.182

4.  Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.

Authors:  Lais Pessanha de Carvalho; Thaisa Lucas Sandri; Edésio José Tenório de Melo; Rolf Fendel; Peter G Kremsner; Benjamin Mordmüller; Jana Held
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

5.  Microfilariae recurrence in graded murrah buffalo treated with repeated doses of ivermectin.

Authors:  L Rajkumar; G S Sreenivasa Murthy
Journal:  J Parasit Dis       Date:  2013-06-23

6.  Neutrophil activation in ivermectin-treated onchocerciasis patients.

Authors:  F L Njoo; C E Hack; J Oosting; J S Stilma; A Kijlstra
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

7.  [Ocular onchocerciasis: a key role for Wolbachia].

Authors:  G Kluxen; A Hörauf
Journal:  Ophthalmologe       Date:  2007-10       Impact factor: 1.059

Review 8.  Ivermectin, 'wonder drug' from Japan: the human use perspective.

Authors:  Andy Crump; Satoshi Ōmura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

Review 9.  Broadening the range of use cases for ivermectin - a review of the evidence.

Authors:  Christian Kositz; John Bradley; Harry Hutchins; Anna Last; Umberto D'Alessandro; Michael Marks
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-03-02       Impact factor: 2.455

10.  Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin.

Authors:  Alexander Yaw Debrah; Sabine Mand; Yeboah Marfo-Debrekyei; John Larbi; Ohene Adjei; Achim Hoerauf
Journal:  Filaria J       Date:  2006-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.